HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-NOV-15 5EYC TITLE CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NAPHTHYRIDINONE INHIBITOR 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1048-1351; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PHOSPHOTRANSFERASE, INHIBITOR, CANCER, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.WHITTINGTON,A.M.LONG REVDAT 4 27-SEP-23 5EYC 1 JRNL REMARK REVDAT 3 06-APR-16 5EYC 1 JRNL REVDAT 2 17-FEB-16 5EYC 1 JRNL REVDAT 1 10-FEB-16 5EYC 0 JRNL AUTH A.A.BOEZIO,K.W.COPELAND,K.REX,B.K ALBRECHT,D.BAUER, JRNL AUTH 2 S.F.BELLON,C.BOEZIO,M.A.BROOME,D.CHOQUETTE,A.COXON, JRNL AUTH 3 I.DUSSAULT,S.HIRAI,R.LEWIS,M.H.LIN,J.LOHMAN,J.LIU, JRNL AUTH 4 E.A.PETERSON,M.POTASHMAN,R.SHIMANOVICH,Y.TEFFERA, JRNL AUTH 5 D.A.WHITTINGTON,K.R.VAIDA,J.C.HARMANGE JRNL TITL DISCOVERY OF JRNL TITL 2 (R)-6-(1-(8-FLUORO-6-(1-METHYL-1H-PYRAZOL-4-YL)-[1,2, JRNL TITL 3 4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)ETHYL)-3-(2-METHOXYETHOXY)-1, JRNL TITL 4 6-NAPHTHYRIDIN-5(6H)-ONE (AMG 337), A POTENT AND SELECTIVE JRNL TITL 5 INHIBITOR OF MET WITH HIGH UNBOUND TARGET COVERAGE AND JRNL TITL 6 ROBUST IN VIVO ANTITUMOR ACTIVITY. JRNL REF J.MED.CHEM. V. 59 2328 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26812066 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01716 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 82.5 REMARK 3 NUMBER OF REFLECTIONS : 21619 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1183 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 637 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 34.21 REMARK 3 BIN R VALUE (WORKING SET) : 0.3730 REMARK 3 BIN FREE R VALUE SET COUNT : 38 REMARK 3 BIN FREE R VALUE : 0.4480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2297 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 255 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.06 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : 1.91000 REMARK 3 B33 (A**2) : -1.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.167 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.106 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.440 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2396 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1636 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3250 ; 1.156 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3977 ; 0.855 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 288 ; 5.180 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 100 ;32.960 ;23.200 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 417 ;12.997 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;11.069 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2600 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 489 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5EYC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000215664. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX HR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22824 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.03400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 37.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.686 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 4XMO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 4000, 3% (V/V) ETHANOL, 6% REMARK 280 (V/V) ISOPROPANOL, 40 MM BETA-MERCAPTOETHANOL, 100 MM HEPES (PH REMARK 280 7.8), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.03650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.01000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.63350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.01000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.03650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 21.63350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 LYS A 1103 REMARK 465 GLY A 1346 REMARK 465 GLU A 1347 REMARK 465 HIS A 1348 REMARK 465 TYR A 1349 REMARK 465 VAL A 1350 REMARK 465 HIS A 1351 REMARK 465 HIS A 1352 REMARK 465 HIS A 1353 REMARK 465 HIS A 1354 REMARK 465 HIS A 1355 REMARK 465 HIS A 1356 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1203 -18.14 80.12 REMARK 500 ASP A1204 42.36 -142.68 REMARK 500 ALA A1221 -162.56 -124.88 REMARK 500 THR A1289 -108.83 47.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1755 DISTANCE = 6.29 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5SZ A 1401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EYD RELATED DB: PDB DBREF 5EYC A 1048 1351 UNP P08581 MET_HUMAN 1048 1351 SEQADV 5EYC HIS A 1352 UNP P08581 EXPRESSION TAG SEQADV 5EYC HIS A 1353 UNP P08581 EXPRESSION TAG SEQADV 5EYC HIS A 1354 UNP P08581 EXPRESSION TAG SEQADV 5EYC HIS A 1355 UNP P08581 EXPRESSION TAG SEQADV 5EYC HIS A 1356 UNP P08581 EXPRESSION TAG SEQRES 1 A 309 GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO SEQRES 2 A 309 GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SEQRES 3 A 309 SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG SEQRES 4 A 309 GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP SEQRES 5 A 309 ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU SEQRES 6 A 309 ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU SEQRES 7 A 309 THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN SEQRES 8 A 309 VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SEQRES 9 A 309 SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP SEQRES 10 A 309 LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR SEQRES 11 A 309 VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS SEQRES 12 A 309 GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS ARG SEQRES 13 A 309 ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE SEQRES 14 A 309 THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET SEQRES 15 A 309 TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR GLY SEQRES 16 A 309 ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU SEQRES 17 A 309 GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER SEQRES 18 A 309 PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA SEQRES 19 A 309 PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL SEQRES 20 A 309 TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR SEQRES 21 A 309 CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP SEQRES 22 A 309 HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU SEQRES 23 A 309 VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY SEQRES 24 A 309 GLU HIS TYR VAL HIS HIS HIS HIS HIS HIS HET 5SZ A1401 29 HETNAM 5SZ 6-[(1~{R})-1-[8-FLUORANYL-6-(3-METHYL-1,2-OXAZOL-5-YL)- HETNAM 2 5SZ [1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL]ETHYL]-1,6- HETNAM 3 5SZ NAPHTHYRIDIN-5-ONE FORMUL 2 5SZ C20 H15 F N6 O2 FORMUL 3 HOH *255(H2 O) HELIX 1 AA1 ASP A 1054 LEU A 1058 5 5 HELIX 2 AA2 ASN A 1059 GLU A 1061 5 3 HELIX 3 AA3 LEU A 1062 VAL A 1069 1 8 HELIX 4 AA4 GLY A 1072 SER A 1074 5 3 HELIX 5 AA5 GLU A 1120 PHE A 1134 1 15 HELIX 6 AA6 ASP A 1164 ASN A 1171 1 8 HELIX 7 AA7 THR A 1177 LYS A 1198 1 22 HELIX 8 AA8 ALA A 1206 ARG A 1208 5 3 HELIX 9 AA9 PHE A 1223 ARG A 1227 5 5 HELIX 10 AB1 ASP A 1231 TYR A 1235 5 5 HELIX 11 AB2 PRO A 1246 MET A 1250 5 5 HELIX 12 AB3 ALA A 1251 GLN A 1258 1 8 HELIX 13 AB4 THR A 1261 THR A 1278 1 18 HELIX 14 AB5 ASN A 1288 PHE A 1290 5 3 HELIX 15 AB6 ASP A 1291 GLN A 1298 1 8 HELIX 16 AB7 PRO A 1309 TRP A 1320 1 12 HELIX 17 AB8 LYS A 1323 ARG A 1327 5 5 HELIX 18 AB9 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 6 VAL A1070 ILE A1071 0 SHEET 2 AA1 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA1 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 AA1 6 ILE A1105 LYS A1110 -1 N ALA A1108 O LEU A1157 SHEET 5 AA1 6 CYS A1091 LEU A1097 -1 N LEU A1097 O ILE A1105 SHEET 6 AA1 6 LEU A1076 ARG A1086 -1 N ILE A1084 O VAL A1092 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 SER A1236 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 16 ILE A1084 VAL A1092 ALA A1108 LEU A1157 SITE 2 AC1 16 PRO A1158 TYR A1159 MET A1160 ASP A1164 SITE 3 AC1 16 ASN A1167 ARG A1208 ASN A1209 MET A1211 SITE 4 AC1 16 ALA A1221 ASP A1222 TYR A1230 HOH A1572 CRYST1 42.073 43.267 158.020 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023768 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023112 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006328 0.00000